drugset / Trial / NCT06657300

Assessment and Comparison of Efficacy of Intra-Articular PRP and Corticosteroid in First CMC Joint OA Treatment

NCT06657300

Phase 4 Completed 60 enrolled Antalya Training and Research Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Aim: We aim to determine and compare the efficiency of single dose intra-articular (IA) platelet rich plasma (PRP) and corticosteroid (CS) injections for the treatment of first carpometacarpal joint osteoarthritis (1. CMC OA) on the basis of pain, hand function and pinch strength. Material and Method: Sixty patients meeting the criteria were included in the study. Patients were randomized into Group 1 (PRP group) or Group 2 (CS group). Patients were evaluated by Visual Analogue Scale (VAS), Duruoz Hand Index (DHI) and pinch meter for pain and function.

Timeline

Start
2022-02-01
Primary completion
2022-07-30
Completion
2022-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 20 mg Other
Subject PRP Unknown 1 ml Other

Indications